AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Dan Moreau
Investor's Business Daily
Top mutual funds in 2000 drew on the often sizzling performance of financials, energy, services and even tech stocks to deliver big gains.
But it took biotech and health care to produce triple-digit returns. Health sector funds that include everything from biotechs to medical equipment makers and health maintenance organizations dominated the year (see chart). Only a handful of non-health funds, such as Fidelity Select
Natural Gas and American Eagle Capital Appreciation, managed to make the list.
Even list-topper Schroeder Micro Cap Investor took much of its 148% gain going into Friday from health sector stocks. Among its top holdings are Respironics and Serologicals. Respironics makes products that fight asthma, lung and breathing problems. Serologicals makes blood-typing agents and other biotech products.
More important, Respironics was up more than 310 for the year going into Thursday. Serologicals was up 156%. Ira Unschuld, who has run Schroeder Micro Cap for three years, was no slouch the previous year, either. The fund gained 95% in 1999. In 1998, it was up 63%.